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Spectra focused on the CT product are shown for the lowest standard indicated in Figure 5, one 
standard higher, and the serum negative control for each volume analyzed.  Spectra were 
smoothed once with a correlation factor of 0.7.  Signal to noise values (S/N) were calculated 
from deisotoped spectra. 
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Focused spectra for the lower 3 standards 50 
ng/mL (A), 20 ng/mL (B), 10 ng/ml (C), and 
negative serum control (D), show the carboxy 
terminal (CT) LF cleavage product at 1607.8 
m/z and corresponding CT-ISTD at 1614.8 
m/z. 
Full spectra for animals A and B on day 2 of 
infection are shown along with inset focused 
spectra of the quantitative targets, CT product and 
CT-ISTD peptide peaks which gives a visual 
picture of the target area ratio.
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